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Abstract L-selectin guides lymphocytes into peripheral lym-
phoid tissues by recognizing glycoprotein ligands decorated with
6-sulfated sialyl Lewis x (sulfo sLex). Here we have used a rat
peripheral lymph node high endothelial cell line (Ax) to study in
detail the synthesis, expression and degradation of sLex epitope.
We show here that Ax cells possess active K(1,3)fucosyltransfer-
ase Fuc-TVII, the enzyme responsible for the final fucosylation
of sialyl-N-acetyllactosamine during sLex synthesis, and express
sLex on the cell surface. Furthermore, these cells degrade sLex,
primarily by desialylating it to neutral Lex epitopes by
K(2,3)sialidase(s).
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1. Introduction
Leukocyte tethering to and rolling on endothelial cells,
mediated by selectins and their oligosaccharide-bearing coun-
terreceptors, initiates the extravasation cascade. L-selectin,
which is expressed on leukocytes, recognizes endothelial mu-
cins GlyCAM-1, CD34 and MAdCAM-1 and guides lympho-
cytes to lymphoid tissues via high endothelial cells [1,2]. The
oligosaccharides on these endothelial mucins contain
K(2,3)sialic acid, K(1,3)fucose and 6-sulfate, which are crucial
in the primary recognition [3]. The specialized endothelial cells
in lymph nodes express sialyl Lewis x (sLex) epitope [4], which
is one of the simplest oligosaccharides that interact with L-
selectin. At parenchymal tissues, in£ammatory stimuli can de
novo induce endothelium to express sLex-containing glycans
[5,6]. The ¢nal reaction in the synthesis of sLex is the K(1,3)fu-
cosylation of a sialyl-N-acetyllactosamine acceptor. Of the ¢ve
cloned human K(1,3)fucosyltransferases (Fuc-TIII^Fuc-TVII),
Fuc-TVII has been suggested to have a pivotal role in the
biosynthesis of endothelial ligands of L-selectin [7].
A high endothelial cell line Ax, established from the rat
peripheral lymph nodes [8], has been shown to incorporate
sulfate and bind L-selectin-IgG fusion protein, among other
features typical of high endothelial cells [9]. In this study, Ax
cells were also shown to express sLex-containing glycans.
These cells possess Fuc-TVII and synthesize sLex from sial-
yl-N-acetyllactosamine acceptor. In addition, Ax cells degrade
their own sLex epitopes, primarily by desialylating them to
Lex, while a small amount also undergoes a defucosylation.
The enzymatic machinery to control the expression of sLex
motifs on various cell surface sca¡olds might be important in
the regulation of selectin-dependent leukocyte extravasation.
2. Materials and methods
2.1. Cell cultures
The Ax cell line was generated and cultured as previously described
[9]. Fuc-TIV and Fuc-TVII transfected CHO cells were kindly pro-
vided by Dr. J.B. Lowe, Howard Hughes Medical Institute, Ann
Arbor, MI,, USA [10,11].
2.2. Antibodies and £ow cytometry
mAb 2H5 against sLex was a gift from Dr. R. Kannagi, Research
Institute, Aichi Cancer Center, Nagoya, Japan, mAb FH-6 against
di-sLex (NeuNAcK2,3GalL1,4(FucK1,3) GlcNAcL1,3GalL1,4-
(FucK1,3)GlcNAc) was kindly provided by Dr. S. Hakomori, The
Biomembrane Institute, Seattle, WA, USA, and mAb CSLEX1
against sLex/di-sLex was a gift from Dr. Olli Lassila, University of
Turku, Finland. mAb KM-93 against sLex/di-sLex was provided by
Dr. K. Shitara, Kyowa Hakko Kogyo Co. Ltd, Tokyo, Japan. Anti-
murine Fuc-TVII antibody was kindly provided by Dr. J.B. Lowe
[12]. Flow cytometry was performed as previously described [13].
Negative controls included isotype matched sialyl Lewis a monoclonal
antibody or deletion of the relevant primary antibody.
2.3. Reverse transcriptase PCR
Total RNA from Ax cells was extracted and cDNA was synthesized
according to standard protocols. Two Wl of the resulting cDNA was
subjected to 30 cycles of PCR ampli¢cation. The sequence of the
forward primer for Fuc-TVII was GTGCATGTGG ATGACTTTGG
(no. 948^967 in U08112 in GenBank) and the reverse primer for Fuc-
TVII TGAAACCAAC CCTCAAGGTC (no. 1156^1137 in U08112).
The Fuc-TVII cDNA was used as a positive control and PCR per-
formed on the cDNA prepared without reverse transcriptase as a
negative control. Each PCR cycle consisted of a denaturing step at
94‡C for 1 min, annealing at 59‡C for 1 min, and extension at 72‡C
for 1 min. The sequence of the forward primer for GAPDH was
GTCTTCACCACC ATGGAGAAGGCT (no. 365^388 in X02231)
and for the reverse primer (TGTAGCCCAGGA TGCCCTTTAGTG
(no. 893^870 in X02231). Each cycle for GAPHD synthesis consisted
of 1 min at 92‡C, 1 min at 55‡C and 1 min at 72‡C. The ampli¢ed
products were electrophoresed on 1.5% agarose gel stained with ethi-
dium bromide and visualized under a UV-lamp. The cDNAs for hu-
man Fuc-TIII^Fuc-TVII were provided by Dr. J.B. Lowe.
2.4. Northern blot
Total RNA was extracted according to standard protocols. 15^30
Wg samples of RNA were size-fractionated on 0.8% agarose-formal-
dehyde gels, transferred on a nylon ¢lter, dried and baked at +80‡C
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and hybridized with cDNA probe labelled with [K-32P]CTP. After
washings the ¢lter was exposed to X-ray ¢lms.
2.5. K(1,3)fucosyltransferase assay
Cell extracts for fucosyltransferase assays were prepared by lysing
107 Ax cells in 300 Wl of 1% Triton X-100 with 0.1 mM PMSF.
Acceptor NeuNAcK2-3GalL1-4GlcNAc from Oxford Glycosystems
(250 nmol/reaction), donor GDP-[14C]fucose from NEN, Boston,
MA, USA (speci¢c activity 283 mCi/mmol, 0.35 nmol/reaction) and
cell lysate were incubated 5 h at 37‡C. The reaction and character-
ization of the reaction products were performed as described earlier
[13].
2.6. Synthesis of the radiolabelled sLex heptasaccharide
The primer hexasaccharide NeuNAcK2-3GalL1-4GlcNAcL1-
3(GlcNAcL1-6)GalL1-4GlcNAc was synthesized enzymatically from
N-acetyllactosamine with human serum L(1,3)N-acetylglucosaminyl-
transferase, bovine milk L(1,4)galactosyltransferase purchased from
Sigma, rat serum L(1,6)N-acetylglucosaminyltransferase, and human
placenta K(2,3)sialyltransferase [14]. The hexasaccharide was K(1,3)fu-
cosylated with partially puri¢ed K(1,3/4)fucosyltransferase from hu-
man milk. The acceptor saccharide (1.2 nmol), donor GDP-
[14C]fucose (2.4 nmol), MnCl2 (16 mM), MOPS-NaOH (50 mM,
pH 7.5), NaCl (0.1 M), BSA (0.5 mg/ml), NaN3 (0.04%) and 15 WU
of enzyme in 10 Wl of total volume were incubated for 72 h at 37‡C.
The reaction mixture was diluted with H2O and the radiolabelled sLex
glycan was puri¢ed with an ion-exchange column.
2.7. Glycosidase assay with the radiolabelled sLex heptasaccharide
Nine pmol/reaction of radioactive sLex-bearing heptasaccharide
substrate (NeuNAcK2-3GalL1-4([14C]FucK1-3)GlcNAcL1-3(GlcNAc-
L1-6)GalL1-4GlcNAc) was dried in the reaction tube and 10 Wl of
100 mM sodium acetate bu¡er (pH 5.0) and 10 Wl of Ax cell lysate
(see above) were added. As a negative control, the substrate was
incubated with the bu¡er and detergent without the cells. The reac-
tions were incubated for 18 h at 37‡C. Termination of the reaction
and characterization of the reaction products were performed as de-
scribed previously [13].
3. Results and discussion
3.1. Ax cells express sLex motifs
High endothelial cells synthesize mucin-like glycoproteins,
such as GlyCAM-1 and CD34, which act as ligands for L-
selectin. Post-translational decorations on these glycoproteins,
containing sLex or sulfated sLex, are of vital importance in
regard to selectin-dependent cell recognition [1,2]. By using
several anti-sLex antibodies we demonstrated that Ax cells
expressed sLex/di-sLex epitope recognized by mAbs KM-93,
FH-6 and 2H5. On the other hand, one anti-sLex mAb,
CSLEX1, showed no reactivity (Fig. 1).
3.2. Ax cells express Fuc-TVII transcripts
Studies in gene knock-out mice suggest an essential role of
Fuc-TVII in L-selectin ligand biosynthesis [7]. Both in situ
hybridization and immunohistochemistry have suggested the
presence of Fuc-TVII in the high endothelial venules in mur-
ine lymph nodes [12]. To analyze whether Fuc-TVII is present
in the cultured rat high endothelial cells, we isolated mRNA
from these cells, transcribed it to cDNA, and subjected it and
the control human Fuc-TVII cDNA to ampli¢cation by Fuc-
TVII primers. One cDNA band of the expected size from Ax
cDNA as well as from the control Fuc-TVII cDNA was syn-
thesized, while nothing was synthesized in the corresponding
negative control (Fig. 2a).
As the cloned K(1,3)fucosyltransferases are highly homolo-
gous, we size-fractionated the PCR products and showed with
Southern blotting, that PCR products hybridized only with
the full length human Fuc-TVII, but not with Fuc-TIII,
Fuc-TIV, Fuc-TV or Fuc-TVI cDNA probes (Fig. 2b). The
alignment of our new sequence from the PCR ampli¢cation
and murine Fuc-TVII DNA show 76% homology suggesting
that the former represented the previously unidenti¢ed rat
Fuc-TVII sequence (Table 1).
Reverse transcriptase PCR experiments show that though
transcripts corresponding to all ¢ve cloned K(1,3)fucosyltrans-
ferases can be identi¢ed from leukocytes, only two of them are
present in quantities large enough to be detected by Northern
blot analyses [11,15]. To analyze the actual level of Fuc-TVII
transcript expression in cultured high endothelial cells we per-
formed Northern blots, and as shown in Fig. 2c, two strong
bands at 1.5 and 3.0 kb were detectable, as previously shown
in HL60 cells as well [11]. The expression of Fuc-TVII has
been studied also in other endothelial cells. Cytokine activa-
tion of human umbilical vein endothelial cells or transfection
of Fuc-TVII cDNA to sLex-negative endothelial cell line in-
duce Fuc-TVII transcription and expression of L-selectin li-
gands, which points out the crucial role of Fuc-TVII [16,17].
3.3. Ax cells possess Fuc-TVII protein
Intracellular immunoperoxidase staining with the rabbit
polyclonal antibody raised against a murine Fuc-TVII peptide
Fig. 1. Expression of sLex on the surface of Ax cells analyzed by
£ow cytometry. For negative control the cells were incubated with
the isotype matched control antibody (white curve). One representa-
tive experiment out of three is presented.
Table 1
Comparison of the murine and proposed rat Fuc-TVII DNA se-
quence; residues that exactly match are marked with a line; in the
overall 202 residues 76% homology was seen between the murine
and rat sequences
FEBS 22286 12-7-99 Cyaan Magenta Geel Zwart
M.-L. Majuri et al./FEBS Letters 455 (1999) 97^10098
[12] showed that Ax cells expressed Fuc-TVII at the protein
level (Fig. 3). CHO cells transfected either with Fuc-TVII or
Fuc-TIV cDNA were cultured on chamber slides and used as
positive and negative controls, respectively. The staining pat-
tern in both the Ax and CHO-Fuc-TVII cells was perinuclear
corresponding to the Golgi localization of this enzyme.
3.4. Ax cells have functional K(1,3)fucosyltransferase
After showing that Ax cells express sLex glycans and Fuc-
TVII capable of synthesizing these epitopes we measured
the K(1,3)fucosyltransferase activity as incorporation of
[14C]fucose from GDP-[14C]fucose to exogenous sialyl-N-ace-
tyllactosamine acceptor. The Ax cell lysate transferred 4 pmol
of fucose to the acceptor in a 5 h assay. The structure of the
reaction product was con¢rmed to be sLex NeuNAcK2-
3GalL1-4([14C]FucK1-3)GlcNAc by glycosidase treatments
and paper chromatographic analysis.
3.5. Ax cells have K(2,3)sialidase and K(1,3)fucosidase
activities
Besides the biosynthesis, it is also interesting to analyze
the catabolism of sLex structures, as the balance of these
two events yields the expression level of sLex at a given
time. To analyze whether degradation of sLex by endothelial
glycosidases would occur, we synthesized enzymatically the
radiolabelled sLex-containing glycan NeuNAcK2-3GalL1-
4([14C]FucK1 -3)GlcNAcL1 - 3(GlcNAcL1 -6)GalL1-4GlcNAc.
The proximal N-acetyllactosaminyl unit was required for the
protection of the otherwise very easily L-eliminated fucosyl
residue. The L(1,6)GlcNAc branch was necessary to prevent
the fucosylation of the proximal N-acetyllactosaminyl unit
during the synthesis [18].
When 9.0 pmol of [14C]-labelled sLex heptasaccharide was
incubated with Ax cell lysate for 18 h, 73% of the original
molecule became desialylated, representing neutral [14C]-gly-
cans and eluting with H2O from the ion-exchange column
(Fig. 4A). Concomitantly only 20% of the original structure
remained intact and was eluted with acetic acid. To analyze
further the nature of the neutral [14C]-glycans i.e. whether the
degraded reaction products were defucosylated, we subjected
them to a paper chromatographic run (Fig. 4B). 6.0 pmol
(corresponding to 67% of the original sLex-containing mole-
cule, Fig. 4A) was desialylated and only 0.6 pmol (corre-
sponding to 6% of the original sLex-containing molecule,
Fig. 4A) was defucosylated as identi¢ed by the migration of
the free radioactive [14C]fucose on the paper (Fig. 4B).
Our data indicate that the primary route for sLex degrada-
tion by endothelial cells requires the desialylation of this gly-
can. Ax cells have a strong K(2,3)sialidase activity and also a
minor K(1,3)fucosidase activity. Here, it is not known whether
the defucosylated product originates from the sialylated or the
neutral precursor. In vitro evidence with puri¢ed enzymes had
already suggested that sLex is not degraded by K(1,3)fucosi-
dases, but rather by K(2,3)desialylation [19].
To date, only fragmentary data are available on mamma-
lian sialidases. These can be classi¢ed into three types; the
Fig. 3. Photomicrograph of immunoperoxidase stainings with Fuc-TVII antibody. A: Permeabilized Ax cells stained positively; B: positive con-
trol staining of Fuc-TVII; and C: negative control staining of Fuc-TIV transfected CHO cells.
Fig. 2. Expression of K(1,3)fucosyltransferase Fuc-TVII in Ax high endothelial cell line. a: Detection of RT-PCR products by electrophoresis.
b: The PCR product was probed with Fuc-TIII^Fuc-TVII cDNAs and only Fuc-TVII reacted. c: Ax cells have two Fuc-TVII mRNA tran-
scripts as shown by Northern blot analysis. One representative experiment out of three is presented.
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cytosolic, lysosomal and plasma membrane-bound forms
[20,21]. Currently the cellular localization and the type of
endothelial sialidase(s) are not known. However, we have
shown that the endothelial sialidase activity has a pH opti-
mum around 4.0 suggesting that it is of lysosomal type ([22]
and data not shown) and that desialylation most likely occurs
in lysosomes after internalization from the cell surface.
Taken together, we show here that rat high endothelial cell
line Ax has the functionally active enzymatic machinery to
synthesize sLex from sialylated N-acetyllactosamines and de-
grade sLex to Lex glycans. The synthesis and degradation of
6-sulfated sLex in endothelial cells via these di¡erent path-
ways might be of crucial importance in the pathophysiological
regulation of lymphocyte extravasation and should be consid-
ered as potential site for the development of anti-in£amma-
tory approaches.
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Fig. 4. Degradation of the radiolabelled sLex heptasaccharide by en-
dothelial glycosidases. A: The degradation products were separated
from the intact substrate by ion-exchange column, neutral products
representing desialylated glycans and acidic ones sialoglycans. B:
The nature of the glycans in the neutral fraction was further ana-
lyzed by paper chromatography. Two peaks could be seen: the de-
sialylated fucose-containing glycan (peak 1), which migrated clearly
slower, and the radioactive fucose monosaccharide (peak 2). The
non-radioactive L-fucose was used as a marker.
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